Evidence map›Paper›PMID 31116990›Full record

ArticleCell reports2019

Accessibility to Peptidoglycan Is Important for the Recognition of Gram-Positive Bacteria in Drosophila.

Filipa Vaz, Ilias Kounatidis, Gonçalo Covas, Richard M Parton, Maria Harkiolaki, Ilan Davis, Sergio Raposo Filipe, Petros Ligoxygakis

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Bacteria-Derived Peptidoglycan Triggers a Noncanonical Nuclear Factor-κB-Dependent Response inThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Filipa VazDepartment of Biochemistry, University of Oxford, South Parks Rd., OX1 3QU Oxford, UK; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, 2780-157 Oeiras, Portugal.
Ilias KounatidisDepartment of Biochemistry, University of Oxford, South Parks Rd., OX1 3QU Oxford, UK; Diamond Light Source, Ltd., Harwell Science and Innovation Campus, OX11 0DE Didcot, UK.
Gonçalo CovasInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, 2780-157 Oeiras, Portugal; UCIBIO-REQUIMTE, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.
Richard M PartonDepartment of Biochemistry, University of Oxford, South Parks Rd., OX1 3QU Oxford, UK.
Maria HarkiolakiDiamond Light Source, Ltd., Harwell Science and Innovation Campus, OX11 0DE Didcot, UK.
Ilan DavisDepartment of Biochemistry, University of Oxford, South Parks Rd., OX1 3QU Oxford, UK.
Sergio Raposo FilipeInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Avenida da República, 2780-157 Oeiras, Portugal; UCIBIO-REQUIMTE, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal. Electronic address: sfilipe@fct.unl.pt.
Petros LigoxygakisDepartment of Biochemistry, University of Oxford, South Parks Rd., OX1 3QU Oxford, UK. Electronic address: petros.ligoxygakis@bioch.ox.ac.uk.
University of Oxford · GBDiamond Light Source · GBRede de Química e Tecnologia · PT

Funding

Biotechnology and Biological Sciences Research Council BB/P005691/1Medical Research Council G0300170Wellcome TrustWellcome Trust 091911/B/10/ZWellcome Trust 107457/Z/15/Z
6 · The paper itself

Abstract

In Drosophila, it is thought that peptidoglycan recognition proteins (PGRPs) SA and LC structurally discriminate between bacterial peptidoglycans with lysine (Lys) or diaminopimelic (DAP) acid, respectively, thus inducing differential antimicrobial transcription response. Here, we find that accessibility to PG at the cell wall plays a central role in immunity to infection. When wall teichoic acids (WTAs) are genetically removed from S. aureus (Lys type) and Bacillus subtilis (DAP type), thus increasing accessibility, the binding of both PGRPs to either bacterium is increased. PGRP-SA and -LC double mutant flies are more susceptible to infection with both WTA-less bacteria. In addition, WTA-less bacteria grow better in PGRP-SA/-LC double mutant flies. Finally, infection with WTA-less bacteria abolishes any differential activation of downstream antimicrobial transcription. Our results indicate that accessibility to cell wall PG is a major factor in PGRP-mediated immunity and may be the cause for discrimination between classes of pathogens.

Indexed as

AnimalsAntimicrobial Cationic PeptidesBacillus subtilisCarrier ProteinsCell WallDrosophilaDrosophila ProteinsImmunity, InnateMutagenesisPeptidoglycanProtein BindingRecombinant ProteinsStaphylococcus aureusTeichoic AcidsTranscriptional ActivationAntimicrobial Cationic PeptidesCarrier ProteinsDrosophila ProteinsPeptidoglycanpeptidoglycan recognition proteinRecombinant ProteinsTeichoic AcidsB. subtilisDrosophilainnate immunitypeptidoglycanPGRPsS. aureusTagO

Identifiers

PMID31116990
PMCPMC6533200
OpenAlexW2945078075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.